International, multicentre: Perhexiline in Aortic Stenosis study.

Effects of perhexiline on the symptomatic status in elderly patients with severe aortic stenosis.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12606000004561

Acronym

IMPASS

Enrollment

Registered

2006-01-04

Start date

1999-06-01

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Too see if perhexilin can decrease the symptoms of chest pain and breathlessness in people who have severe aortic stenosis.

Interventions

Perhexiline 100mgs BD for 8 weeks.

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Treatment

Masking

Blinded (masking used)

Eligibility

Sex/Gender

All

Age

0 to No maximum

Healthy volunteers

Inclusion criteria

AVA of < 0.1cm sq. Symptoms of angina and/or exertional shortness of breath.

Exclusion criteria

No exclusion criteria

Outcome results